Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C
Macías, J.; Mira, J.é A.; López-Cortés, L.F.; Santos, I.; Girón-González, J.é A.; González-Serrano, M.; Merino, D.; Hernández-Quero, J.é; Rivero, A.; Merchante, N.ás.; Trastoy, M.ón.; Carrillo-Gómez, R.; Arizcorreta-Yarza, A.; Gómez-Mateos, J.ús.; Pineda, J.A.
Antiviral Therapy 11(7): 839-846
2006
ISSN/ISBN: 1359-6535 PMID: 17302241 Document Number: 600826
Document emailed within 1 workday
Related Documents
Sherman, K.E.; Shire, N.J.; Cernohous, P.; Rouster, S.D.; Omachi, J.H.; Brun, S.; Da Silva, B. 2005: Liver injury and changes in hepatitis C virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients : Lopinavir-ritonavir versus nelfinavir Clinical Infectious Diseases 41(8): 1186-1195Arystanbekova, M.; Balmasova, I.; Malova, E.; Sepiashvili, R. 2017: Antiretroviral Therapy and the Risk of Liver Fibrosis Progression in Hiv/Hcv Coinfected Patients Georgian Medical News 266: 58-63
Li, Z.-C.; Li, H.-J.; Dai, L.-L.; Gao, Y.-Q.; Cai, W.-P.; Li, H.-Y.; Huang, X.-J.; Zhang, T.; Wu, H. 2010: Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy Chinese Medical Journal 123(24): 3587-3590
Takashima, T.; Iijma, H.; Nishiguchi, S. 2015: Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF) Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 145-149
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Vardar, R.; Vardar, E.; Demiri, S.; Sayhan, S.E.; Bayol, U.; Yildiz, C.şk.; Postaci, H. 2009: Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepato-Gastroenterology 56(94-95): 1459-1465
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Zhong, L.-H.; Jiang, Y.-M.; Lou, G.-Q.; Yu, X.-L.; Liu, H.; Guo, J.-C.; Zhu, M.-F.; Xun, Y.-H. 2013: The relationship between serum HBsAg levels and liver inflammation and fibrosis in patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 27(2): 92-94
Mendes-Correa, M.C.ás.; Widman, A.; Brussi, M.L.P.; Guastini, C.F.át.; Gianini, R.J.é 2008: Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil Aids Patient Care and Stds 22(9): 701-707
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Fierbinteanu-Braticevici, C.; Papacocea, R.; Tribus, L.; Cristian, B. 2014: Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C Indian Journal of Medical Research 140(1): 123-129
Kunde, K. 2000: HIV therapy: toxic liver injuries caused by protease inhibitors? Deutsche Medizinische Wochenschrift 125(12): A12-A13
Mankhatitham, W.; Luaengniyomkul, A.; Manosuthi, W. 2012: Lipid profile changes in Thai HIV and tuberculosis co-infected patients receiving non-nucleoside reverse transcriptase inhibitors-based antiretroviral therapy Journal of the Medical Association of Thailand 95(2): 163-169
Flisiak, R.; Maxwell, P.; Prokopowicz, D.; Timms, P.M.; Panasiuk, A. 2002: Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis Hepato-Gastroenterology 49(47): 1369-1372
Rao, H-ying.; Wei, L.; Li, J.; Zhang, L-fang.; Chen, H-yong.; Zhu, L-min.; Liu, F.; Sun, Y.; Wang, H. 2009: Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response Hepato-Gastroenterology 56(90): 328-334
Kryczka, W.ła.; Chrapek, M.; Zarebska-Michaluk, D. 2005: Assessment of the usefulness of combination of selected clinical and demographic parameters in prediction of the severity of liver fibrosis in patients with chronic hepatitis C Przeglad Epidemiologiczny 59(2): 395-403
Lanini, S.; Bartolini, B.; Taibi, C.; Agresta, A.; Garbuglia, A.R.; Montaldo, C.; Pisapia, R.; D'Offizi, G.; Scognamiglio, P.; Capobianchi, M.R.; Zumla, A.; Ippolito, G. 2019: Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: a cohort study New Microbiologica 42(3): 139-144
Soriano, V.; Rivas, P.; Nuñez, M. 2008: Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(11): 1486-1489
Piatkowska, M.; Kotschy, M.; Rość, D.; Wiśniewska, E.; Opoka, J. 1994: Plasma serine protease inhibitors in patients with liver cirrhosis Acta Haematologica Polonica 25(2): 145-149
Sommadossi; Murphy 1997: Protease Inhibitors Therapy for AIDS Patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 1(5): 226-229